Literature DB >> 11754070

Clinical, genetic, and biochemical characterization of a Leber hereditary optic neuropathy family containing both the 11778 and 14484 primary mutations.

M D Brown1, J C Allen, G P Van Stavern, N J Newman, D C Wallace.   

Abstract

Four mitochondrial DNA (mtDNA) mutations at nps 3460, 11778, 14484, and 14459 account for roughly 90% of cases of Leber hereditary optic neuropathy (LHON) and are designated as "primary" LHON mutations since they act as major predisposition factors for LHON. Although each primary mutation can arise independently on different mtDNA backgrounds during human evolution, they characteristically do not co-occur in LHON patients. We report here a family with the simultaneous occurrence of the 11778A and 14484C mutations. Neuro-ophthalmological examination of the proband, a nine-year-old Caucasian female, revealed the bilateral optic atrophy, central scotomas, and reduced visual acuity typical of LHON. Her mother had normal appearing optic discs and is today visually asymptomatic. Analysis of the proband blood mtDNA revealed that she harbored both the 11778A (heteroplasmic, 94% mutant) and the 14484C (homoplasmic mutant) mutation. This genotype was maintained in proband lymphoblasts and transmitochondrial cybrids. The mother also had both mutations, with the 14484C mutation homoplasmic in all cell types examined. However, only 31% of her blood mtDNAs carried the 11778 mutation, which segregated to essentially 100% wild-type in lymphoblast and cybrid mtDNA. Complex I-linked respiration and specific enzyme activity were consistently lowest in proband lymphoblast and cybrid mitochondria compared to those from the mother, 11778A patients, 14484C patients, or controls, thus demonstrating both a deleterious synergistic interaction between the 11778A and 14484C mutations and the magnitude of 11778A-associated complex I dysfunction. Remarkably, spontaneous vision recovery occurred in the proband, highlighting the complexities encountered when associating mtDNA genotype and complex I function with LHON expression. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11754070

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  21 in total

1.  Mitochondrial mutation in Iranian patients with multiple sclerosis, correlation between haplogroups H, A and clinical manifestations.

Authors:  Mojdeh Ghabaee; Motahar Omranisikaroudi; Shahla Amrisaroukolaei; Alipasha Meysamie; Mohammad Ali Sahraian; Asghar Bayati; Mohammad Hossein Sanati; Mossoud Houshman; Homa Sadeghian; Khalili Vajihazaman
Journal:  Cell Mol Neurobiol       Date:  2008-11-14       Impact factor: 5.046

Review 2.  The neurodegenerative mitochondriopathies.

Authors:  Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 3.  The Potential Application of Mitochondrial Medicine in Toxicologic Poisoning.

Authors:  David H Jang; Joshua W Lampe; Lance B Becker
Journal:  J Med Toxicol       Date:  2015-06

4.  Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial.

Authors:  Carolyn Hoppe; Eufemia Jacob; Lori Styles; Frans Kuypers; Sandra Larkin; Elliott Vichinsky
Journal:  Br J Haematol       Date:  2017-03-28       Impact factor: 6.998

Review 5.  Bioenergetic origins of complexity and disease.

Authors:  D C Wallace
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2011-12-22

6.  Superoxide generation explains common features of optic neuropathies associated with cecocentral scotomas.

Authors:  Leonard A Levin
Journal:  J Neuroophthalmol       Date:  2015-06       Impact factor: 3.042

7.  Mitochondrial DNA variant associated with Leber hereditary optic neuropathy and high-altitude Tibetans.

Authors:  Fuyun Ji; Mark S Sharpley; Olga Derbeneva; Leonardo Scherer Alves; Pin Qian; Yaoli Wang; Dimitra Chalkia; Maria Lvova; Jiancheng Xu; Wei Yao; Mariella Simon; Julia Platt; Shiqin Xu; Alessia Angelin; Antonio Davila; Taosheng Huang; Ping H Wang; Lee-Ming Chuang; Lorna G Moore; Guisheng Qian; Douglas C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-18       Impact factor: 11.205

8.  Mouse mtDNA mutant model of Leber hereditary optic neuropathy.

Authors:  Chun Shi Lin; Mark S Sharpley; Weiwei Fan; Katrina G Waymire; Alfredo A Sadun; Valerio Carelli; Fred N Ross-Cisneros; Peter Baciu; Eric Sung; Meagan J McManus; Billy X Pan; Daniel W Gil; Grant R Macgregor; Douglas C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-05       Impact factor: 11.205

Review 9.  Molecular genetic testing for mitochondrial disease: from one generation to the next.

Authors:  Elizabeth McCormick; Emily Place; Marni J Falk
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

10.  Specifications of the ACMG/AMP standards and guidelines for mitochondrial DNA variant interpretation.

Authors:  Elizabeth M McCormick; Marie T Lott; Matthew C Dulik; Lishuang Shen; Marcella Attimonelli; Ornella Vitale; Amel Karaa; Renkui Bai; Daniel E Pineda-Alvarez; Larry N Singh; Christine M Stanley; Stacey Wong; Anshu Bhardwaj; Daria Merkurjev; Rong Mao; Neal Sondheimer; Shiping Zhang; Vincent Procaccio; Douglas C Wallace; Xiaowu Gai; Marni J Falk
Journal:  Hum Mutat       Date:  2020-11-10       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.